mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
5e-05 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
9e-05 |
mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0001 |